{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"groups":[{"description":"Matched unrelated donor allogeneic stem cell transplantation with a conditioning regimen of targeted busulfan, cyclophosphamide and thymoglobulin.","id":"OG000","title":"Unrelated Donor Allogeneic"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"count of participants represents number of participants with documented acute GVHD prior to day 100 post transplant.","reportingStatus":"POSTED","timeFrame":"at day 100 post transplantation","title":"Incidence of Grade II-IV Acute Graft-versus-host-disease (GVHD)","type":"SECONDARY","unitOfMeasure":"Participants"}